NCT06263439 Surveillance of HFMD in Pediatric Outpatients
| NCT ID | NCT06263439 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Hand, Foot and Mouth Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-06-20 |
| Primary Completion | 2028-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2023-06-20 with a primary completion date of 2028-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangina in children seen within an ambulatory setting : * to detect an EV-A71 epidemic or another type associated with atypical forms of the disease at an early stage * to describe and compare the epidemiological, demographic, clinical and virological characteristics of these infections between the different types of EV.
Eligibility Criteria
Inclusion Criteria: * Children aged 0 to 10 years presenting with HFMD or herpangina Exclusion Criteria: * Refusal to participate by holders of parental authority * Refusal to participate for children over 3 years of age
Contact & Investigator
Audrey MIRAND
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT06263439 clinical trial?
This trial is open to participants of all sexes, up to 10 Years, studying Hand, Foot and Mouth Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06263439 currently recruiting?
Yes, NCT06263439 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06263439 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT06263439 clinical trial?
NCT06263439 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Audrey MIRAND at University Hospital, Clermont-Ferrand. The trial plans to enroll 3,000 participants.